Us Bancorp \De\ Olink Holding Ab (Publ) Transaction History

Us Bancorp \De\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$21.87 - $25.59 $1,115 - $1,305	-51 Reduced 0.57%	8,943 $227,000
Q1 2024 May 07, 2024	SELL	$21.81 - $25.14 $719 - $829	-33 Reduced 0.37%	8,994 $211,000
Q4 2023 Feb 09, 2024	SELL	$14.29 - $25.95 $4,872 - $8,848	-341 Reduced 3.64%	9,027 $227,000
Q3 2023 Nov 03, 2023	SELL	$14.45 - $20.34 $4,306 - $6,061	-298 Reduced 3.08%	9,368 $138,000
Q2 2023 Aug 09, 2023	BUY	$17.13 - $23.74 $148,585 - $205,920	8,674 Added 874.4%	9,666 $181,000
Q1 2023 May 09, 2023	SELL	$19.34 - $24.11 $696 - $867	-36 Reduced 3.5%	992 $22,000
Q4 2022 Feb 13, 2023	BUY	$12.64 - $25.52 $3,804 - $7,681	301 Added 41.4%	1,028 $26,000
Q3 2022 Oct 27, 2022	BUY	$12.14 - $18.42 $1,408 - $2,136	116 Added 18.99%	727 $9,000
Q2 2022 Aug 01, 2022	SELL	$8.95 - $19.24 $707 - $1,519	-79 Reduced 11.45%	611 $9,000
Q3 2021 Nov 10, 2021	SELL	$23.42 - $37.93 $1,100 - $1,782	-47 Reduced 6.38%	690 $16,000
Q2 2021 Aug 05, 2021	BUY	$26.65 - $39.47 $16,283 - $24,116	611 Added 484.92%	737 $25,000
Q1 2021 Apr 28, 2021	BUY	$31.9 - $36.0 $4,019 - $4,536	126 New	126 $5,000

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.